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1973 and Seligmann et al., 1973), generally
however one must conclude that until very
recently there was no convincing evidence for
success. Recently, however, several en-
couraging results have been reported. For
example, Metzgar and colleagues (Monhana-
kumar, Metzgar and Miller, 1974) have
raised antisera in monkeys which appear to
distinguish different leukaemic cells from
each other and from normal cells. Baker and
Taub (Baker, Ramachander and Taub, 1975)
have raised antisera in mice rendered tolerant
to normal lymphocyte antigens, which appear
to have similar properties.
We have raised antisera in rabbits to
acute lymphoblastic leukaemic (ALL) cells by
injecting these cells coated with antibodies to
normal lymphocytes. The binding of the
antisera to various cell types has been studied
using immunofluorescent reagents and the
analytical capacity of the Fluorescence
Activated Cell Sorter-I (FACS-1) and their
full characteristics are described fully else-
where (Greaves et al., 1975; Brown, Capellaro
and Greaves, 1975). In summary, after
absorption with red cells, liver and tonsil
lymphocytes, the anti-ALL sera do not react
with normal resting or dividing foetal or
adult lymphocytes and appear on the basis of
absorption studies to define three leukaemia
associated antigens.
1. A " weak " antigen shared with my-
elocytes, myeloblastic leukaemia cells
and foetal liver (haemopoietic) cells,
2. A strong antigen shared with a subset of
intermediate normoblasts found in
normal bone marrow and early foetal
liver, and
3. An antigen found so far only on non-T
cell ALLs, which we regard as a strong
candidate for a leukaemia specific
antigen.
We have used antisera to ALL to distin-
guish between non-T ALL, T cell type ALL
and other acute leukaemias in untreated
patients and more recently have begun to
screen patients considered to be in remission
for rare leukaemic cells which migbt indicate
residual disease and/or early signs of relapse.
The results indicate that leukaemic cells are
demonstrable in remission patients. Analy-
sis of cell populations with antileukaemic sera
may therefore have important diagnostic and
prognostic potential.
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NEOPLASMS OF THE IMMUNE
SYSTEM: CLASSIFICATION BY
PRESUMED CELL OF ORIGIN
R. D. COLLINS, Vanderbilt University School
of Medicine, Nashville, Tennessee.
Current classifications of malignant
lymphomata were developed before the
complexities of the immunological system
were recognized, and are defective by not
providing a conceptual approach to the
relationship between lymphoid neoplasms
and normal lymphocyte populations. Lukes
and Collins (1974a, b) have recently outlined a
classification oflymphoid neoplasms based on
modern concepts of the immune system, as
well as histological features (Table I). The
basic tenet of this proposal is that malignant
lymphomata, as neoplasms of the immune
system, should be classified according to the
kind of lymphocyte from which they arise.
Although the clinical usefulness of this
proposed classification has not been tested,
preliminary studies indicate that most
lymphoid neoplasms may be satisfactorily
categorizedbyacombinationoffunctionaland
structural investigations.
For example, in a recent study at Vander-
bilt (Leech et al., 1974; Glick et al., 1974), cells282 REPORT OF THE LEUKAEMIA RESEARCH FUND
TABLE-Classification of Malignant
Lymphomata (Modfied from Lukes and
Collins 1974a, b)
I. Undefined cell type
II. T-cell types
1. Thymic lymphoma (convoluted lympho-
cytic)
2. Node based T cell lymphoma
3. Mycosis fungoides and Sezary's syndrome
4. T cell ALL and CLL
5. ? Immunoblastic sarcoma (of T cells)
6. ? Hodgkin's disease
III. B-cell types
1. Small lymphocyte (CLL)
2. Plasmacytoid lymphocytic
:3. Follicular-centre cell (FCC) types
(a) small cleaved
(b) large cleaved
(c) small transformed-Burkitt's lympho-
ma
(d) large transformed
4. Immunoblastic sarcoma (of 13 cells)
IV. Histiocytic types
VT. Unclassifiable.
from lymphomata containing neoplastic
follicular structures with one exception had
surface Ig, and closely resembled follicular
centre cells (FCC) ultrastructurally. Similar
findings were described in those diffuse
lymphomata containing, by light microscopy,
cleaved FCC or a mixture of cleaved and
transformed FCC. FCC lymphomata made
up 58% of the 45 consecutive lymphomata
studied. These studies further showed that
many lymphomata previously diagnosed as
" histiocytic " lymphoma were composed of
cells which bore surface Ig, did not have the
cytochemical reactions of histiocytes, and
were similar to transformed lymphocytes by
ultrastructural examination. A complex
group of neoplasms of T cell origin, some
arising in lymph nodes, was found.
On the basis of these and similar studies
of a small number of cases, it seems likely
that each sub-population of lymphoid cells
may give rise to a distinct neoplasm, and that
lymphoid neoplasms may be usefully classified
by a combined functional and structural
evaluation (Table I). The use of such
classifications will significantly improve inter-
change ofinformation about normal lymphoid
populations with information about lymphoid
neoplasms. By this approach, relationships
between diseases with altered immunological
functions and lymphoid malignancies will be
more apparent, relationships between
lymphoid neoplasms primarily affecting the
marrow and lymphoid neoplasms primarily
involving the extramarrow tissues may be
established, and perhaps most importantly,
lymphoid neoplasms may be used more
effectively to study the normal lymphoid
apparatus.
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METHODS FOR THE STUDY OF
CELL DIFFERENTIATION IN
ACUTE LEUKAEMIA
D. CATOVSKY, M.R.C. Leukaemia Unit,
Royal Postgraduate Medical School, London.
The aim ofthe study of cell differentiation
in acute leukaemia (AL) is to improve our
means of recognizing the different cell types
involved in the neoplastic process and to
establish a firm basis for a classification ofthe
disease. This may help in the identification
of groups that vary in response to treatment
and in prognosis, and could lead to improved
selection of patients for different types of
treatment. Some ofthe methods used are:
1. Cell morphology
On Romanowsky-stained films. A high
standard of film spreading, fixation and
staining permits the recognition of already
well-differentiated cells in acute myeloid
leukaemia (AML); i.e. cells containing
azurophil granules, Auer rods, etc. Some
distinct variants of AML, like promyelocytic
leukaemia, may be diagnosed easily from
these preparations.
2. Cytochemistry
Myeloperoxidase and nonspecific esterase
reactions do help in the assessment of early
myeloblastic or monoblastic differentiation in